AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimismall M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Ambitious Pharmaceutical Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimismall M 1mg/500mg Tablet

Diabexe Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabexe Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabexe Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is vital, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Glimismall M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimismall M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Glimismall M 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glimismall M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimismall M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimismall M 1mg/500mg Tablet should be administered with a meal.

How Glimismall M 1mg/500mg Tablet works:

Glimismall M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimismall M 1mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimismall M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Nursing mothers should avoid Glimismall M 1mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimismall M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glimismall M 1mg/500mg tablet use. Medical supervision, including regular kidney function assessment, is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimismall M 1mg/500mg tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate treatment with a reduced Glimismall M 1mg/500mg tablet dosage; its use is contraindicated in cases of severe liver disease.

What if you forget to take Glimismall M 1mg/500mg Tablet :

Should you forget to take a Glimismall M 1mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimismall M 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Diabetes medication

FAQs on Glimismall M 1mg/500mg Tablet

Maintain this medication within its original, securely sealed container. Follow the storage guidelines specified on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Glimismall M 1mg/500mg Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this uncommon side effect poses a significant risk to individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms can include muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Glimismall M 1mg/500mg Tablet use and seek immediate medical attention.
Glimismall M 1mg/500mg tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus. This medication enhances glycemic control in adults when combined with a healthy diet and physical activity. Glimepiride stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin concurrently reduces hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Glimismall M 1mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, prolonged Glimismall M 1mg/500mg Tablet use can lead to Vitamin B12 insufficiency. This medication disrupts Vitamin B12 absorption within the gastrointestinal tract. Left unaddressed, this deficiency might result in anemia, neurological complications, such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental Vitamin B12 intake, at a minimum, annually, has been proposed by some studies.
Indeed, Glimismall M 1mg/500mg Tablets can induce hypoglycemia. Low blood sugar symptoms may present as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. A readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, should always be carried.
Combining Glimismall M 1mg/500mg tablets and alcohol is unsafe. Alcohol consumption can exacerbate the medication's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Glimismall M 1mg/500mg Ta...
45
MRP 55
18% off